Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002481:Cellulitis / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects*; D002512:Cephalothin / Q000008:administration & dosage / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004890:Erythema / Q000139:chemically induced; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D010689:Phlebitis / Q000139:chemically induced*; D011014:Pneumonia / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects; D018805:Sepsis / Q000188:drug therapy; D013440:Sulfides / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D000081:Acetamides; D000890:Anti-Infective Agents; D002511:Cephalosporins; D005839:Gentamicins; D011725:Pyridines; D013440:Sulfides; D002512:Cephalothin